Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
Clinical trial NCT02503501 · TERMINATED
Trial details
- NCT number
- NCT02503501
- Sponsor
- HealthPartners Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-28
- Primary completion
- 2019-02-11
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.